Nivolumab (NIVO) + ipilimumab (IPI) versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1 Meeting Abstract
| Authors: | Thomas, M.; Ramalingam, S. S.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Schenker, M.; Bernabé Caro, R.; Lee, K. H.; Zurawski, B.; Audigier-Valette, C.; Provencio, M.; Linardou, H.; Kim, S. W.; Borghaei, H.; Hellmann, M. D.; O'Byrne, K. J.; Paz-Ares, L. G.; Reck, M.; Nathan, F. E.; Brahmer, J. R. |
| Abstract Title: | Nivolumab (NIVO) + ipilimumab (IPI) versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1 |
| Meeting Title: | 2020 Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (DGHO) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Oct 9-11 |
| Meeting Location: | Virtual |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-10-01 |
| Start Page: | 140 |
| End Page: | 141 |
| Language: | English |
| ACCESSION: | WOS:000575955000322 |
| PROVIDER: | wos |
| DOI: | 10.1159/000510995 |
| Notes: | Meeting Abstract: 220 -- "2020 Virtual Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Source: Wos |
